We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLRS
7101
Kalaris Therapeutics
KLRS
$99.9M
$27K ﹤0.01%
1,621
-792
-33% -$14K
GEOS icon
7102
Geospace Technologies
GEOS
$87.6M
$26.9K ﹤0.01%
2,997
+2,994
+99,800% +$33.7K
NEUP
7103
Neuphoria Therapeutics
NEUP
$21.2M
$26.8K ﹤0.01%
2,908
+2,080
+251% +$22.7K
EFU icon
7104
ProShares Trust UltraShort MSCI EAFE
EFU
$1.15M
$26.7K ﹤0.01%
1,750
-822
-32% -$12.6K
IGEB icon
7105
iShares Investment Grade Systematic Bond ETF
IGEB
$1.46B
$26.6K ﹤0.01%
+600
New +$26.5K
VGZ icon
7106
Vista Gold
VGZ
$295M
$26.6K ﹤0.01%
57,204
+38,092
+199% +$19.8K
GMAR icon
7107
FT Vest US Equity Moderate Buffer ETF March
GMAR
$396M
$26.6K ﹤0.01%
+750
New +$25.9K
IVVD icon
7108
Invivyd
IVVD
$192M
$26.5K ﹤0.01%
24,104
+22,736
+1,662% +$50.2K
HSPOU
7109
DELISTED
Horizon Space Acquisition I Corp Unit
HSPOU
$26.5K ﹤0.01%
2,664
-10
-0.4% -$109
VRM icon
7110
Vroom Inc
VRM
$48.6M
$26.5K ﹤0.01%
2,838
+2,811
+10,411% +$31.3K
ANGI icon
7111
Angi Inc
ANGI
$204M
$26.4K ﹤0.01%
1,376
+121
+10% +$2.62K
GPAK
7112
DELISTED
Gamer Pakistan Inc. Common Stock
GPAK
$26.4K ﹤0.01%
133,334
+94,648
+245% +$21.6K
ULS icon
7113
UL Solutions
ULS
$15.5B
$26.3K ﹤0.01%
+624
New +$23.6K
LKFT
7114
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.71B
$26.2K ﹤0.01%
1,056
-321
-23% -$9.11K
IMPP icon
7115
Imperial Petroleum
IMPP
$211M
$26.2K ﹤0.01%
6,741
+2,513
+59% +$9.3K
RMCF icon
7116
Rocky Mountain Chocolate Factory
RMCF
$7.93M
$26.1K ﹤0.01%
+11,861
New +$37.4K
OILU icon
7117
MicroSectors Oil & Gas Exp. & Prod. 3x Leveraged ETN
OILU
$62.7M
$26K ﹤0.01%
647
+34
+6% +$1.5K
CRUZ
7118
DELISTED
Defiance Hotel, Airline, and Cruise ETF
CRUZ
$26K ﹤0.01%
+1,189
New +$26K
PALC icon
7119
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
$218M
$26K ﹤0.01%
534
+313
+142% +$14.5K
TONX
7120
TON Strategy Co
TONX
$162M
$25.9K ﹤0.01%
1,046
+548
+110% +$17.3K
JDZG
7121
JIADE Ltd
JDZG
$19.6M
$25.9K ﹤0.01%
+16
New +$170K
TSDD icon
7122
GraniteShares 2x Short TSLA Daily ETF
TSDD
$31.2M
$25.8K ﹤0.01%
+83
New +$37K
CHN
7123
DELISTED
China Fund
CHN
$25.8K ﹤0.01%
2,547
+2,477
+3,539% +$26.1K
BENF icon
7124
Beneficient
BENF
$44M
$25.7K ﹤0.01%
1,450
+1,440
+14,400% +$46.9K
SEF icon
7125
ProShares Short Financials
SEF
$13M
$25.7K ﹤0.01%
614
-265
-30% -$11.2K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.